Département de radiothérapie, centre François-Baclesse, 3, avenue Général-Harris, 14000 Caen, France; Service de radiothérapie, CHU Dupuytren, 2, avenue Martin-Luther-King, 87042 Limoges cedex, France.
Unité de physique médicale, centre Eugène-Marquis, rue de La Bataille-Flandres-Dunkerque, CS 44229, 35042 Rennes cedex, France.
Cancer Radiother. 2022 Feb-Apr;26(1-2):156-167. doi: 10.1016/j.canrad.2021.10.007. Epub 2021 Dec 22.
We present the update of the recommendations of the French society of radiotherapy and oncology on the indications and the technical methods of carrying out radiotherapy of sinonasal cancers. Sinonasal cancers (nasal fossae and sinus) account for 3 to 5% of all cancers of the head and neck. They include carcinomas, mucosal melanomas, sarcomas and lymphomas. The management of sinonasal cancers is multidisciplinary but less standardized than that of squamous cell carcinomas of the upper aerodigestive tract. As such, patients with sinonasal tumors can benefit from the expertise of the French expertise network for rare ENT cancers (Refcor). Knowledge of sinonasal tumour characteristics (histology, grade, risk of lymph node involvement, molecular characterization, type of surgery) is critical to the determination of target volumes. An update of multidisciplinary indications and recommendations for radiotherapy in terms of techniques, target volumes and radiotherapy fractionation of the French society of radiotherapy and oncology (SFRO) was reported in this manuscript.
我们提出了法国放射肿瘤学会关于开展鼻腔鼻窦癌放射治疗的适应证和技术方法的建议更新。鼻腔鼻窦癌（鼻腔和鼻窦）占头颈部所有癌症的 3%至 5%。它们包括癌、黏膜黑色素瘤、肉瘤和淋巴瘤。鼻腔鼻窦癌的治疗是多学科的，但不如上呼吸道鳞状细胞癌那样标准化。因此，鼻腔鼻窦肿瘤患者可以受益于法国罕见耳鼻喉癌症专业知识网络（Refcor）的专业知识。了解鼻腔鼻窦肿瘤的特征（组织学、分级、淋巴结受累风险、分子特征、手术类型）对于确定靶区至关重要。本文报告了法国放射肿瘤学会（SFRO）在技术、靶区和放疗分割方面对多学科适应证和放射治疗建议的更新。
